Professor, Director Pediatric Hem/Onc, Director MSU center for Bleeding and Clotting DisorderDepartment of Pediatrics and Human Development, Michigan State University, East Lansing, MI, USAEast Lansing, Michigan, United States
OC 69.5 - Outcomes in Adult and Adolescent Patients With Severe Hemophilia A in the Phase 3 XTEND-1 Study Who Switched to Efanesoctocog Alfa Prophylaxis From an Observational Study With Factor VIII Prophylaxis
Wednesday, June 28, 202311:15 – 11:30 ET
